Fairhaven Health presents clinical study results for FertilAid for Men
BELLINGHAM, Wash. Fairhaven Health, which manufactures a male fertility supplement, recently presented a clinical study at the American Society of Andrology’s annual meeting, the company announced Tuesday.
Results from a recent clinical study indicate that FertilAid for Men provides significant improvements in sperm quality for men with abnormal sperm parameters. In particular, results of the 90-day, double blind, placebo-controlled study suggest that FertilAid for Men supports significant increases in the total number of normal motile sperm. Previous clinical studies have suggested a strong relationship between the “total normal-motile sperm count” and the fertility of the man.
“Most of the men that had increased sperm counts while taking FertilAid for Men also showed improvements of 20% or more in the number of healthy sperm,” stated lead researcher J. Ellington.
FertilAid for Men is a male fertility supplement that integrates vitamins, antioxidants, a proprietary blend of herbal ingredients and the amino acid, l-carnitine. Scientific literature suggests that antioxidants can improve male fertility by reducing oxidative stress and damage to spermatozoa, while supporting fundamental protective functions of the seminal plasma which insulate and nourish sperm. In independent studies, antioxidants reduce “free-radical” damage, in particular to the sperm’s DNA or genetic material, resulting in better pregnancy outcomes.
Research on the amino acid, l-carnitine, yields similar pro-fertility findings: L-carnitine supports “sperm metabolism”, or the ability for sperm to break down complex molecules to produce energy. L-carnitine has been shown in a number of clinical studies to enhance several fundamental sperm parameters, including sperm concentration, motility and normal morphology.
Fairhaven Health’s distribution partners include drugstore.com, BabyCenter and CVS.com, as well as a number of clinics and private practices nationwide.
Bayer Consumer Care launches virtual march against breast cancer
MORRISTOWN, N.J. Bayer Consumer Care last week announced an initiative encouraging women to join a virtual march against breast cancer as part of its One A Day Women’s Take A Stand Campaign.
Through the end of October, women will have the opportunity to show that they’re taking a stand against breast cancer by going to www.oneaday.com, and creating a customizable character in honor of someone special.
According to a recent Yankelovich survey, although a large majority of women know there are simple steps they can take to support breast health, few women are taking the necessary actions. As many as 80% of the women surveyed have been personally affected by breast cancer or know someone who has been.
The survey also found that 1-in-5 women who support breast health or breast cancer awareness causes wish they could do more, and 60% of women who have not supported breast cancer organizations and causes say they lack the time or money.
“Joining the Take A Stand virtual march provides a quick, easy and free way for women to help raise funds to support breast cancer awareness and research,” Bayer stated. “For each character created, the One A Day brand will make a donation to a breast cancer cause that will be determined by an online vote.”
The organizations to be included in that vote are: The Breast Cancer Research Foundation, the American Cancer Society and the National Breast Cancer Foundation.
“This program is part of our continued efforts to increase awareness about the importance of supporting breast health,” stated Barton Warner, VP marketing and new business for Bayer Consumer Care. “Last year One A Day Women’s woke women up about breast cancer through the One A Day Women’s Wake-Up Call program, and now it’s time women answer the call by taking a stand.”
BDI Marketing announces new wave of energy drinks
CARMEL, Ind. BDI Marketing announced the release of a new series of products, including its new 357 Super Magnum Energy Shot, Xtreme Energy Rush and Top Gun sexual stimulant pills in a new 2-oz. liquid shot.
BDI’s 357 Super Magnum Energy Shot provides consumers with enough caffeine to stimulate and fuel the body to perform at unparralled levels throughout the entire day but without the fat, sugar, carbohydrates or calories, the company said.
In celebration of the 10th anniversary of the introduction of its popular Top Gun sexual stimulant pills, BDI is now offering the product in new two-ounce liquid shots, available in Cherry Passion flavors. The pill is aimed to provide consumers with enhanced libido and increased energy and endurance.
Xtreme Energy Rush is packed with three-times the strength of a single cup of coffee; a triple strength punch that provides the body with a shot of long lasting energy.
The new products join BDI’s ever-growing family of incredibly popular liquid, gum and capsule Mini Thin energy products to provide consumers with a delicious option to high-sugar energy drinks.